By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Cancer Institute is seeking clinically annotated biospecimens for a number of cancer types that it will use in The Cancer Genome Atlas (TCGA) program, a collaboration with the National Human Genome Research Institute which aims to study at least 20 cancers over the next five years.

NCI expects that it will need more than 40,000 biosamples to supply TCGA over the coming years to study all of these cancer varieties.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: methylation patterns in multiple myeloma, recent Y chromosome bottleneck, and more.

By studying the spectra of microbes on Earth, a team of researchers hopes to be better equipped to detect any on other worlds.

SolveBio's Mark Kaganovich says at TechCrunch that genomics needs an app to push it into the mainstream.

A University of Michigan team is using a Facebook app to recruit and keep in touch with participants in its 'Genes for Good' project.

Apr
15
Sponsored by
WaferGen

This live online seminar will highlight recent trends in applying next-generation sequencing in the clinical setting, with a particular focus on oncology and rare disease.